Sun Pharma Increases Investment in US-Based Pharmazz to Expand Specialty Therapeutics Portfolio
Sun Pharma has signed an agreement to invest up to $25 million in US-based Pharmazz, increasing its stake to approximately 22.7% on a fully diluted basis.
© Copyright 2025. All Rights Reserved by MedPath